PURPOSE: To establish the feasibility of shorter acquisition times (and by analogy, applied activity) on tumour detection and lesion contrast in digital PET/CT. METHODS: Twenty-one randomly selected patients who underwent oncological [18F]-FDG PET/CT on a digital PET/CT were retrospectively evaluated. Scan data were anonymously obtained and reconstructed in list-mode acquisition for a standard 2 min/bed position (bp), 1 min/bp and 30 s/bp (100%, 50% and 25% time or applied activity, respectively). Scans were randomized and read by two nuclear medicine physicians in a consensus read. Readers were blind to clinical details. Scans were evaluated for the number of pathological lesions detected. Measured uptake for lesions was evaluated by maximum and mean standardized uptake value (SUVmax and SUVmean, respectively) and tumour-to-backround ratio (TBR) were compared. Agreement between the three acquisitions was compared by Krippendorf's alpha. RESULTS: Overall n = 100 lesions were identified in the 2 min and 1 min/bp acquisitions and n = 98 lesions in the 30 s/bp acquisitions. Agreement between the three acquisitions with respect to lesion number and tumour-to-background ratio showed almost perfect agreement (K's α = 0.999). SUVmax, SUVmean and TBR likewise showed > 98% agreement, with longer acquisitions being associated with slightly higher mean TBR (2 min/bp 7.94 ± 4.41 versus 30 s/bp 7.84 ± 4.22, p < 0.05). CONCLUSION: Shorter acquisition times have traditionally been associated with reduced lesion detectability or the requirement for larger amounts of radiotracer activity. These data confirm that this is not the case for new-generation digital PET scanners, where the known higher sensitivity results in clinically adequate images for shorter acquisitions. Only a small variation in the semi-quantitative parameters SUVmax, SUVmean and TBR was seen, confirming that either reduction of acquisition time or (by analogy) applied activity can be reduced as much as 75% in digital PET/CT without apparent clinical detriment.
PURPOSE: To establish the feasibility of shorter acquisition times (and by analogy, applied activity) on tumour detection and lesion contrast in digital PET/CT. METHODS: Twenty-one randomly selected patients who underwent oncological [18F]-FDG PET/CT on a digital PET/CT were retrospectively evaluated. Scan data were anonymously obtained and reconstructed in list-mode acquisition for a standard 2 min/bed position (bp), 1 min/bp and 30 s/bp (100%, 50% and 25% time or applied activity, respectively). Scans were randomized and read by two nuclear medicine physicians in a consensus read. Readers were blind to clinical details. Scans were evaluated for the number of pathological lesions detected. Measured uptake for lesions was evaluated by maximum and mean standardized uptake value (SUVmax and SUVmean, respectively) and tumour-to-backround ratio (TBR) were compared. Agreement between the three acquisitions was compared by Krippendorf's alpha. RESULTS: Overall n = 100 lesions were identified in the 2 min and 1 min/bp acquisitions and n = 98 lesions in the 30 s/bp acquisitions. Agreement between the three acquisitions with respect to lesion number and tumour-to-background ratio showed almost perfect agreement (K's α = 0.999). SUVmax, SUVmean and TBR likewise showed > 98% agreement, with longer acquisitions being associated with slightly higher mean TBR (2 min/bp 7.94 ± 4.41 versus 30 s/bp 7.84 ± 4.22, p < 0.05). CONCLUSION: Shorter acquisition times have traditionally been associated with reduced lesion detectability or the requirement for larger amounts of radiotracer activity. These data confirm that this is not the case for new-generation digital PET scanners, where the known higher sensitivity results in clinically adequate images for shorter acquisitions. Only a small variation in the semi-quantitative parameters SUVmax, SUVmean and TBR was seen, confirming that either reduction of acquisition time or (by analogy) applied activity can be reduced as much as 75% in digital PET/CT without apparent clinical detriment.
Entities:
Keywords:
Digital PET; List mode acquisition; PET/CT; Positron emission tomography
Authors: Francisco Fuentes-Ocampo; Diego Alfonso López-Mora; Albert Flotats; Gabriela Paillahueque; Valle Camacho; Joan Duch; Alejandro Fernández; Anna Domènech; Montserrat Estorch; Ignasi Carrió Journal: Eur J Nucl Med Mol Imaging Date: 2019-01-07 Impact factor: 9.236
Authors: Nghi C Nguyen; Jose L Vercher-Conejero; Abdus Sattar; Michael A Miller; Piotr J Maniawski; David W Jordan; Raymond F Muzic; Kuan-Hao Su; James K O'Donnell; Peter F Faulhaber Journal: J Nucl Med Date: 2015-07-09 Impact factor: 10.057
Authors: Joyce van Sluis; Ronald Boellaard; Rudi A J O Dierckx; Gilles N Stormezand; Andor W J M Glaudemans; Walter Noordzij Journal: J Nucl Med Date: 2019-10-18 Impact factor: 10.057
Authors: Suleman Surti; Varsha Viswanath; Margaret E Daube-Witherspoon; Maurizio Conti; Michael E Casey; Joel S Karp Journal: J Nucl Med Date: 2020-03-20 Impact factor: 11.082
Authors: Daniëlle Koopman; Pieter L Jager; Cornelis H Slump; Siert Knollema; Jorn A van Dalen Journal: EJNMMI Res Date: 2019-12-10 Impact factor: 3.138
Authors: Hasan Sari; Mohammadreza Teimoorisichani; Clemens Mingels; Ian Alberts; Vladimir Panin; Deepak Bharkhada; Song Xue; George Prenosil; Kuangyu Shi; Maurizio Conti; Axel Rominger Journal: Eur J Nucl Med Mol Imaging Date: 2022-07-19 Impact factor: 10.057
Authors: Ian Alberts; Robin Schepers; Konstantinos Zeimpekis; Hasan Sari; Axel Rominger; Ali Afshar-Oromieh Journal: Eur J Nucl Med Mol Imaging Date: 2022-09-22 Impact factor: 10.057
Authors: Julian M M Rogasch; Frank Hofheinz; Lutz van Heek; Conrad-Amadeus Voltin; Ronald Boellaard; Carsten Kobe Journal: Diagnostics (Basel) Date: 2022-02-10
Authors: Varsha Viswanath; Hasan Sari; Austin R Pantel; Maurizio Conti; Margaret E Daube-Witherspoon; Clemens Mingels; Ian Alberts; Lars Eriksson; Kuangyu Shi; Axel Rominger; Joel S Karp Journal: Eur J Nucl Med Mol Imaging Date: 2022-03-12 Impact factor: 10.057
Authors: Pedro Fragoso Costa; Walter Jentzen; Alissa Brahmer; Ilektra-Antonia Mavroeidi; Fadi Zarrad; Lale Umutlu; Wolfgang P Fendler; Christoph Rischpler; Ken Herrmann; Maurizio Conti; Robert Seifert; Miriam Sraieb; Manuel Weber; David Kersting Journal: BMC Cancer Date: 2022-08-18 Impact factor: 4.638
Authors: Song Xue; Rui Guo; Karl Peter Bohn; Jared Matzke; Marco Viscione; Ian Alberts; Hongping Meng; Chenwei Sun; Miao Zhang; Min Zhang; Raphael Sznitman; Georges El Fakhri; Axel Rominger; Biao Li; Kuangyu Shi Journal: Eur J Nucl Med Mol Imaging Date: 2021-12-24 Impact factor: 10.057